Definitive Healthcare Corp
NASDAQ:DH
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
This alert will be permanently deleted.
Definitive Healthcare Corp
Definitive Healthcare Corp. engages in the provision of healthcare commercial intelligence. The company is headquartered in Framingham, Massachusetts and currently employs 676 full-time employees. The company went IPO on 2021-09-15. The firm provides solutions through its software-as-a-service (SaaS) platform, which provides information on healthcare providers and their activities to help its customers optimize from product development to go-to-market planning and sales and marketing execution. Its platform offers Artificial Intelligence (AI) engine and Front-end SaaS platform. The firm's platform is embedded with deep analytics and data science to help customers develop data-driven strategic decisions, such as finding new markets to enter, building comprehensive go-to-market strategies, accessing tactical information to help target the right decision makers and improving win rates with detailed contextual information. The firm provides services across biopharmaceutical and medical device companies, healthcare information technology companies, healthcare providers and other diversified companies.
Definitive Healthcare Corp. engages in the provision of healthcare commercial intelligence. The company is headquartered in Framingham, Massachusetts and currently employs 676 full-time employees. The company went IPO on 2021-09-15. The firm provides solutions through its software-as-a-service (SaaS) platform, which provides information on healthcare providers and their activities to help its customers optimize from product development to go-to-market planning and sales and marketing execution. Its platform offers Artificial Intelligence (AI) engine and Front-end SaaS platform. The firm's platform is embedded with deep analytics and data science to help customers develop data-driven strategic decisions, such as finding new markets to enter, building comprehensive go-to-market strategies, accessing tactical information to help target the right decision makers and improving win rates with detailed contextual information. The firm provides services across biopharmaceutical and medical device companies, healthcare information technology companies, healthcare providers and other diversified companies.
Revenue & Profit Beat: Q3 revenue was $60 million, at the high end of guidance, and adjusted EBITDA reached $18.9 million, $2 million above guidance.
Revenue Decline: Revenue declined 4% year-over-year, reflecting ongoing challenges, especially in life sciences, but some stabilization is evident.
Improved Retention: Renewal rates improved year-over-year, with enterprise customer count rising by 10 to 520, showing progress in key areas.
Raised Full-Year Guidance: Management increased the midpoint of full-year revenue and profit guidance, now expecting $239–$240 million in revenue and $68–$69 million in adjusted EBITDA for 2025.
Strategic Data Investments: New claims data sources brought online, returning data coverage to historical levels and supporting competitive positioning.
Cautious Outlook: Management remains cautious on the macro environment and expects revenue and net dollar retention to decline into early 2026, with critical renewals in December and January.
